Left Atrial Appendage Occlusion in High Bleeding Risk Patients.
Pierluigi MerellaGiovanni LorenzoniAlessandro P DelitalaFilomena SechiFederica DecandiaGraziana ViolaPaola BerneGianluca DeianaPatrizio MazzoneGavino CasuPublished in: Journal of interventional cardiology (2019)
LAAO is feasible and safe and prevents stroke in patients with AF with contraindication to oral anticoagulant therapy. After LAAO, single antiplatelet therapy seems to be a safe alternative to dual antiplatelet therapy, especially in patients at high bleeding risk. No benefit has been observed with dual APT.